 |
 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Konyne 80.
No reviews have yet been submitted. Be the first to review this drug.
Medical Encyclopedia:
Recombinant Fc fusion proteins show potential to transform care by providing long-lasting protection from bleeding with fewer injections than the current...
BAX 326 Granted Orphan-drug Designation by U.S. Food and Drug Administration DEERFIELD, Ill.--(BUSINESS WIRE)--Dec 10, 2012 - Baxter International Inc....
Prophylactic regimens resulted in low single-digit annualized bleeding rates -- -- Median dosing interval was 14 days in the individualized interval...
Looking for answers? Ask a question or go join the Konyne 80 support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 16th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
